Mutations in epigenetic regulators bring fitness to Cancer

Mutations in epigenetic regulators are prevalent in cancer, but their functional impact is poorly delineated aside from disrupting differentiation. Loukas, Simeoni, et al. paper zoom in on the late occurring, subclonal subset of such mutations and define the molecular mechanism behind their enrichment in cancer.

Previous post
High-performance multiplex drug-gated CAR circuits Next post
Metabolic symbiosis in pancreatic cancer